Douglass Given Net Worth & Insider Trades

Douglass Given - Director, Arrowhead Pharmaceuticals, Inc

As of May 8, 2023

What is Douglass Given's Net Worth?

The current estimated net worth of Arrowhead Pharmaceuticals, Inc's Director, Douglass Given, is estimated to be about $9.93M . Douglass Given owns about 130,135 units of Arrowhead Pharmaceuticals, Inc common stock. In the last 11 years at Arrowhead Pharmaceuticals, Inc, Douglass Given has sold an estimated value of $5.12M worth.

What is Douglass Given's Past Insider Trading?

Douglass Given's largest purchase order was 65,000 units , worth over $254.57K on February 26, 2019. Douglass Given's largest sale order was 68,000 units , worth over $1.31M on February 26, 2019. In total, Douglass Given has made about 33 transactions over 11 years of their time at Arrowhead Pharmaceuticals, Inc. Douglass Given usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 6,500 units , worth over $265.85K on May 8, 2023.

Douglass Given

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Douglass Given's Salary in 2020?

As Director of Arrowhead Pharmaceuticals, Inc, Douglass Given has a total base salary of $409,615 . Douglass Given received compensation valued at about $16,343,808 in 2020 after becoming Director. The vast majority of their compensation came in the form of stock awards of $15,857,500 , other compensation of $76,693 .

What is Douglass Given's' Mailing Address?

  • Mailing address is C/o Neorx Corp 410 West Harrison St Seattle WA 98119 WA

Arrowhead Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Christopher Anzalone 2020 $785,625 - $12,686,000 - $820,000 $2,892 $14,294,517
Christopher Anzalone 2019 $674,375 - - - $1,540,000 $1,889 $2,216,264
Christopher Anzalone 2018 $643,012 - - - $975,000 $1,889 $1,619,901
Kenneth Myszkowski 2020 $463,750 - $5,391,550 - $213,750 $12,802 $6,081,852
Kenneth Myszkowski 2019 $422,500 - $1,055,700 - $251,550 $11,799 $1,741,549
Kenneth Myszkowski 2018 $384,841 - $276,000 - $180,000 $12,177 $853,018
Javier San Martin 2020 $380,769 $100,000 $7,225,500 - $180,000 $12,802 $7,899,071
Javier San Martin 2019 - - - - - - -
Javier San Martin 2018 - - - - - - -
James Hassard 2020 $302,404 - $7,430,000 - $170,000 $15,892 $7,918,296
James Hassard 2019 - - - - - - -
James Hassard 2018 - - - - - - -
Curt Bradshaw 2020 $338,462 - $6,021,250 - - $13,494 $6,373,206
Curt Bradshaw 2019 - - - - - - -
Curt Bradshaw 2018 - - - - - - -
Bruce D. Given 2020 $409,615 - $15,857,500 - - $76,693 $16,343,808
Bruce D. Given 2019 $488,750 - $2,608,200 - $850,000 $11,799 $3,958,759
Bruce D. Given 2018 $450,362 - $644,000 - $445,900 $11,799 $1,552,061
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm

What are Arrowhead Pharmaceuticals, Inc's Past Insider Trades?

Arrowhead Pharmaceuticals, Inc's most recent insider trade came on May 8, 2023 by Douglass Given who sold 6,500 units worth $265.85K . In the last 19 years, insiders at Arrowhead Pharmaceuticals, Inc have sold an estimated value of $167.38M and bought an estimated value of $10.66M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Christopher Anzalone, Chief Executive Officer,  Kenneth Myszkowski, Chief Financial Officer,  and Charles McKenney, Director .

ARROWHEAD PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...